ProZinc

RSS

insulin human

Authorised
This medicine is authorised for use in the European Union.

Overview

ProZinc is a veterinary medicine used to treat cats and dogs with diabetes. It contains the active substance human insulin.

This EPAR was last updated on 24/06/2019

Authorisation details

Product details
Name
ProZinc
Agency product number
EMEA/V/C/002634
Active substance
insulin human
International non-proprietary name (INN) or common name
insulin human
Species
  • Cats
  • Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QA10AC01
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Revision
8
Date of issue of marketing authorisation valid throughout the European Union
12/07/2013
Contact address
Binger Strasse 73
55216 Ingelheim/Rhein
Germany

Product information

26/04/2019 ProZinc - EMEA/V/C/002634 - II/0015

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Insulins and analogues for injection, intermediate-acting

Therapeutic indication

For the treatment of diabetes mellitus in cats and dogs to achieve reduction of hyperglycaemia and improvement of associated clinical signs.

Assessment history

How useful was this page?

Add your rating